Ionis Pharmaceuticals (IONS) Margins & Profitability 2020-2026

Gross, EBITDA, operating, and net margin trends

Margins

Profit margins across the income statement

Gross Margin: 99.0%
EBITDA Margin: -36.6%
Op. Margin: -38.2%
Net Margin: -42.8%

Op. margin of -38.2% is down 69.1% YoY — costs are rising relative to revenue. Net margin at -42.8% and gross margin of 99.0% show how much of each revenue dollar survives to profit.

Gross Margin (%)

Revenue left after direct cost of goods sold

EBITDA Margin (%)

Operating profitability independent of capital structure

Operating & Net Margins (%)

How much of each dollar becomes profit